George Min, MD
Plastic Surgery · Bellevue, WANPI 1801059225
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (54.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 71.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $8,884 and has fallen 93.7% since, to $556 in 2025. Among plastic surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $106.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Motiva USA, LLC$2K
- Sientra, Inc.$1K
- Revance Therapeutics, Inc.$341
- Boston Scientific$141
- Lilly USA, LLC$130
- plus $310 from 7 others
What the payments were for
- Consulting fees$1,0006%
- Travel & lodging$1,2018%
- Food & beverage$4,86331%
- Gifts$8,41254%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $11,130 |
| Motiva USA, LLC | 9 | $2,079 |
| Sientra, Inc. | 18 | $1,346 |
| Revance Therapeutics, Inc. | 6 | $341 |
| Boston Scientific | 2 | $141 |
| Lilly USA, LLC | 5 | $130 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Medtronic | 1 | $68 |
| KCI USA, Inc. | 1 | $28 |
| Bayer | 1 | $25 |
| Tanabe Pharma America, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $22 |
| Axogen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,476 in reported general payments places this provider in the 90th percentile of 63 plastic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Scopolamine | 30 | $418 |
| Cephalexin | 52 | $349 |
| Ondansetron OdtOndansetron | 41 | $227 |
| Methocarbamol | 34 | $173 |
| Ciprofloxacin Hcl | 20 | $173 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $122 |
| Oxycodone Hcl | 13 | $76 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Bellevue
- Teri BurnettBellevue$10K
- George MarosanBellevue$6K
- Bryan McIntoshBellevue$3K
- David StephensBellevue$1K
- Richard RandBellevue$345
- Allen GabrielVancouver$873K
- Craig BirgfeldSeattle$118K
- Christopher NicholsTacoma$80K
- Suzette MirandaSeattle$75K
- Keith PaigeSeattle$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.